Characterization of Monoclonal Antibodies Oxidation Variants Using Middle-down Approach and Hydrogen/Deuterium Exchange Mass Spectrometry

Importance of the Topic

The rapid expansion of monoclonal antibody therapeutics requires equally fast and reliable analytical strategies to monitor critical quality attributes such as oxidation and other post-translational modifications.
High-resolution mass spectrometry combined with middle-down approaches enables both intact mass measurement and localized variant detection, streamlining quality control workflows.

Objectives and Study Overview

This study aimed to develop a fast separation and analysis method for monoclonal antibody oxidation variants using a middle-down approach and hydrogen/deuterium exchange mass spectrometry.
Four therapeutic antibodies (rituximab, trastuzumab, infliximab, bevacizumab) were fragmented, separated, and analyzed to demonstrate the method’s speed, resolution, and applicability to variant characterization.

Methodology and Instrumentation

• Sample Preparation: Antibodies were reduced with DTT and digested with papain or IdeS to generate light chain, heavy chain, Fc, Fab, single-chain Fc (scFc) and F(ab′)2 fragments.
• Chromatography: A supermacroporous reversed-phase MAbPac RP column (4 μm, 3×50 mm) was run with a 10-minute gradient of water/acetonitrile containing 0.1% formic acid and 0.02% TFA.
• Mass Spectrometry (Intact and Fragment Analysis): Q Exactive Plus Orbitrap was used for accurate mass measurement of intact fragments and variant detection.
• Hydrogen/Deuterium Exchange MS: HDX labeling followed by quenching, on-line pepsin digestion, nano-LC trapping and separation, and analysis on an Orbitrap Fusion Tribrid at 60 000 resolution to monitor local structural changes.

Main Results and Discussion

• Baseline separation of all six fragment types was achieved in a 10-minute LC method.
• Oxidized heavy chain species were fully resolved from non-oxidized counterparts, enabling clear identification of oxidation variants.
• HDX MS revealed a specific increase in deuterium uptake around methionine 255 upon oxidation, indicating a local enhancement of structural dynamics and solvent accessibility.

Benefits and Practical Applications

• High throughput: Rapid 10-minute workflow supports quality control demands in biomanufacturing.
• Fragment-specific insight: Direct middle-down analysis pinpoints modification locations without full peptide mapping.
• Structural characterization: HDX data provide information on variant-induced conformational changes.
• Generic applicability: Method can be applied to diverse mAbs and other biotherapeutics.

Future Trends and Potential Applications

• Integration with glycan profiling and other PTM analyses for comprehensive characterization.
• Automation of sample handling and data processing for higher throughput.
• Coupling with advanced separation techniques (ion mobility, microfluidics) to further enhance resolution.
• Application of AI-driven data analysis to accelerate variant identification and interpretation.

Conclusion

The presented middle-down LC/MS approach combined with HDX MS delivers rapid, high-resolution characterization of monoclonal antibody oxidation variants. Its speed, specificity, and structural insight make it a valuable tool for both research and QC environments in biopharmaceutical development.

Reference

• Liu H., Gaza-Bulseco G., Zhou L. Mass Spectrometry Analysis of Photo-Induced Methionine Oxidation of a Recombinant Human Monoclonal Antibody. J. Am. Soc. Mass Spectrom. 2009, 20(4):525–528.